Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

Abstract The development of brain metastases (BMs) in breast cancer (BC) patients remains a challenging complication. Current clinical practice guidelines recommend local treatment of BMs without changing systemic therapy (CST) in patients with stable extracranial disease. We retrospectively investi...

Full description

Bibliographic Details
Main Authors: Omar Alhalabi, Zaid Soomro, Ryan Sun, Elshad Hasanov, Aya Albittar, Debu Tripathy, Vicente Valero, Nuhad K. Ibrahim
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-021-00235-7

Similar Items

Similar Items